Key facts
- Nalu Medical’s last known valuation is $533.0M.
- It has raised $445.6M across 2 recorded rounds; the latest was Later Stage VC ($115.1M) in Dec 2023.
- Notable investors include StartX (US), B Capital Group, Novo Holdings, Gilde Healthcare, Longitude Capital — 14 tracked in total.
- Nalu Medical has filed 4 Form Ds with the SEC since 2015, most recently Oct 2024 ($115.1M sold to 29 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Nalu Medical
Funding rounds
2 roundsAbout Nalu Medical
Developer of a neurostimulation implant designed to provide long-term relief for patients with intractable chronic nerve pain. The company offers a battery-free, discreet microstimulator system with an external therapy disc that is minimally invasive and easily upgradeable, enabling individuals with persistent pain to manage symptoms effectively without repeated surgeries or reliance on medication.
- Sector
- Healthcare
- HQ
- Carlsbad, CA, United States
- Founded
- 2014
- Employees
- 194
- Website
- nalumed.com/
- Ownership
- Privately Held (backing)
Nalu Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nalu Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nalu Medical in its N-PORT filings yet. We sweep new filings monthly.